Maarten Hulsmans

Maarten Hulsmans

Auto-generated profile, based on publicly available information

Maarten Hulsmans

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Cell
Verified
Journal Article
Closed access
MHMaarten Hulsmans
Maarten Hulsmans
Sebastian ClaussSebastian Clauss
Sebastian Clauss
LXLing Xiao
Ling Xiao
AAAaron D. Aguirre
Aaron D. Aguirre
KKKevin R. King
Kevin R. King
MNMatthias Nahrendorf
Matthias Nahrendorf

11 June 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
GBGeetika Bajpai
Geetika Bajpai
CSCaralin Schneider
Caralin Schneider
NWNicole Wong
Nicole Wong
ABAndrea Bredemeyer
Andrea Bredemeyer
MHMaarten Hulsmans
Maarten Hulsmans
KLKORY J. LAVINE
KORY J. LAVINE

16 January 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MHMaarten Hulsmans
Maarten Hulsmans
HSHendrik B. Sager
Hendrik B. Sager
JRJason D. Roh
Jason D. Roh
MVMaría Valero-Muñoz
María Valero-Muñoz
NHNicholas E. Houstis
Nicholas E. Houstis
MNMatthias Nahrendorf
Matthias Nahrendorf
Macrophages populate the healthy myocardium and, depending on their phenotype, may contribute to tissue homeostasis or disease. Their origin and role in diastolic dysfunction, a hallmark of cardiac aging and heart failure with preserved ejection fraction, remain unclear. Here we show that cardiac macrophages expand in humans and mice with diastolic dysfunction, which in mice was induced by either hypertension or advanced age. A higher murine myocardial macrophage density results from monocyte recruitment and increased hematopoiesis in bone marrow and spleen. In humans, we observed a parallel constellation of hematopoietic activation: circulating myeloid cells are more frequent, and splenic 18F-FDG PET/CT imaging signal correlates with echocardiographic indices of diastolic dysfunction. While diastolic dysfunction develops, cardiac macrophages produce IL-10, activate fibroblasts, and stimulate collagen deposition, leading to impaired myocardial relaxation and increased myocardial stiffness. Deletion of IL-10 in macrophages improves diastolic function. These data imply expansion and phenotypic changes of cardiac macrophages as therapeutic targets for cardiac fibrosis leading to diastolic dysfunction.

16 September 2016 in Circulation Research
Verified
Journal Article
Open access
PDF file
HSHendrik B. Sager
Hendrik B. Sager
MHMaarten Hulsmans
Maarten Hulsmans
KLKory J. Lavine
Kory J. Lavine
MMMarina B. Moreira
Marina B. Moreira
THTimo Heidt
Timo Heidt
MNMatthias Nahrendorf
Matthias Nahrendorf
Rationale:: Macrophages reside in the healthy myocardium, participate in ischemic heart disease, and modulate myocardial infarction (MI) healing. Their origin and roles in post-MI remodeling of nonischemic remote myocardium, however, remain unclear. Objective:: This study investigated the number, origin, phenotype, and function of remote cardiac macrophages residing in the nonischemic myocardium in mice with chronic heart failure after coronary ligation. Methods and Results:: Eight weeks post MI, fate mapping and flow cytometry revealed that a 2.9-fold increase in remote macrophages results from both increased local macrophage proliferation and monocyte recruitment. Heart failure produced by extensive MI, through activation of the sympathetic nervous system, expanded medullary and extramedullary hematopoiesis. Circulating Ly6C high monocytes rose from 64±5 to 108±9 per microliter of blood ( P <0.05). Cardiac monocyte recruitment declined in Ccr2 −/− mice, reducing macrophage numbers in the failing myocardium. Mechanical strain of primary murine and human macrophage cultures promoted cell cycle entry, suggesting that the increased wall tension in post-MI heart failure stimulates local macrophage proliferation. Strained cells activated the mitogen-activated protein kinase pathway, whereas specific inhibitors of this pathway reduced macrophage proliferation in strained cell cultures and in the failing myocardium ( P <0.05). Steady-state cardiac macrophages, monocyte-derived macrophages, and locally sourced macrophages isolated from failing myocardium expressed different genes in a pattern distinct from the M1/M2 macrophage polarization paradigm. In vivo silencing of endothelial cell adhesion molecules curbed post-MI monocyte recruitment to the remote myocardium and preserved ejection fraction (27.4±2.4 versus 19.1±2%; P <0.05). Conclusions:: Myocardial failure is influenced by an altered myeloid cell repertoire.

16 June 2013 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
MHMaarten Hulsmans
Maarten Hulsmans
Paul HolvoetPaul Holvoet
Paul Holvoet
In addition to intracellular organelles, eukaryotic cells contain extracellular organelles which are released, or shed, into the microenvironment. In practice, most human studies have examined mixed populations containing both exosomes and shedding microvesicles (also called ectosomes or microparticles); only a few studies have rigorously distinguished between the two. Accordingly, in this review, exosomes and shedding microvesicles are collectively called microvesicles. The first aim of this review was to discuss the role of microvesicles in cell-to-cell communication in general and in specific interactions between cells in chronic inflammation associated with atherosclerotic disease. Hereby, we focused on cell-specific microvesicles derived from platelets, endothelial cells and monocyte and monocyte-derived cells. The latter were also found to be associated with inflammation in obesity and type 2 diabetes prior to atherosclerotic disease, and cancer. Our second aim was to discuss specific changes in microvesicle content in relation with inflammation associated with metabolic and atherosclerotic disease, and cancer. Because many studies supported the putative diagnostic value of microRNAs, we emphasized therein changes in microRNA content rather than protein or lipid content. The most interesting microRNAs in inflammatory microvesicles in association with metabolic and cardiovascular diseases were found to be the let-7 family, miR-17/92 family, miR-21, miR-29, miR-126, miR-133, miR-146, and miR-155. These data warrant further investigation of the potential of microvesicles as putative biomarkers and as novel carriers for the cell-specific transfer of microRNAs and other therapeutic agents.

14 July 2023 in Science
Verified
Journal Article
Closed access
MHMaarten Hulsmans
Maarten Hulsmans
MSMaximilian J. Schloss
Maximilian J. Schloss
ILI-Hsiu Lee
I-Hsiu Lee
ABAneesh Bapat
Aneesh Bapat
YIYoshiko Iwamoto
Yoshiko Iwamoto
MNMatthias Nahrendorf
Matthias Nahrendorf
Atrial fibrillation disrupts contraction of the atria, leading to stroke and heart failure. We deciphered how immune and stromal cells contribute to atrial fibrillation. Single-cell transcriptomes from human atria documented inflammatory monocyte and SPP1 + macrophage expansion in atrial fibrillation. Combining hypertension, obesity, and mitral valve regurgitation (HOMER) in mice elicited enlarged, fibrosed, and fibrillation-prone atria. Single-cell transcriptomes from HOMER mouse atria recapitulated cell composition and transcriptome changes observed in patients. Inhibiting monocyte migration reduced arrhythmia in Ccr2 −∕− HOMER mice. Cell-cell interaction analysis identified SPP1 as a pleiotropic signal that promotes atrial fibrillation through cross-talk with local immune and stromal cells. Deleting Spp1 reduced atrial fibrillation in HOMER mice. These results identify SPP1 + macrophages as targets for immunotherapy in atrial fibrillation.